Current Standards of Systemic Therapies in Advanced Hepatocellular Cancer: A Review

Hossam Hosny
Additional contact information
Hossam Hosny: Orthopaedic Surgery Department, Sohag University, Egypt

Anatomy Physiology & Biochemistry International Journal, 2016, vol. 1, issue 1, 1-4

Abstract: Sorafenib a multikinase inhibitor is the only approved systemic therapy in the treatment of advanced hepatocellular cancer. No other targeted therapy have proved to be better, a lot of phase 3 trials with many targeted have shown no significant or clinically relevant activity. After SHARP trial no other trial with any other targeted therapy has shown any significant improvement in the treatment of hepatocellular cancer. EACH trial, a phase 3 randomized trial conducted on Asian patients proved better RR and PFS of FOLFOX4 regimen when compared to doxorubicin, showed efficacy and safety of FOLFOX4 protocol. In the light of so many negative phase 3 trials with targeted therapies, it seems only sorafenib still can be considered a standard therapy in advanced HCC.

Keywords: Anatomy Physiology; Biochemistry International Journal; Biochemistry; journal of biochemistry; biochemistry open access journals; open access biochemistry articles; biochemistry journals impact factor list; research journals; research articles; juniper publishers reivew (search for similar items in EconPapers)
Date: 2016
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/apbij/pdf/APBIJ.MS.ID.555551.pdf (application/pdf)
https://juniperpublishers.com/apbij/APBIJ.MS.ID.555551.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:japbij:v:1:y:2016:i:1:p:1-4

DOI: 10.19080/APBIJ.2016.01.555551

Access Statistics for this article

Anatomy Physiology & Biochemistry International Journal is currently edited by Sophia Mathis

More articles in Anatomy Physiology & Biochemistry International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().